ajanta pharma limi Ajanta House, 1 +8222 5606 1000 GPP ajanta p lirrsited — Nrnen tances, F131 22650 190 Mumbai 400 067 | E. info@ajantapharma.com: India W. www.ajantapharma.com: T* March, 2016 BSE LIMITED National Stock Exchange of India, Phiraze Jeejeebhoy Towers Exchange Plaza, 5” Flacr, Plot 0. C/*, G Block, Dalat Steet, andra Kuria Complex, Bandra (East), smurmbal 400.001 Membat -400 054 Dear Sin, Scrip Code: BSE - AJANTPHARM 532331/ NSE - AJANTPHARM EQ Dear Sir/Madam, Sub.: Ajanta Pharma Limited receives 1/ANDA approval from US FDA We are pleased to inform that our Company has received 1 ANDA aparoval from US FDA. We enclose herewith a ares release being issued by the company in this regard, for your information and records. Please acknowledge the receipt. ‘thanking You, Yours faith, for AJANTA PHARMA LIMITED Lo Afr GGAURANG SHAH Se. GM. = Legal & Company Secretary Enel: ala Corgerate Identity Number -.24230MH1979°LC022059Ajanta House T 491226606 1000 . vce regf crutenkerdnt West, | F 121226608 IO GD ajanta pharma limited worries £ Info@elentapnarma com India W waww.ajantapharma.com Ajanta Pharma Receives US FDA Approval for Almotriptan Malate Tablets ‘Mumbai, India - (7 March, 2016) - Ajanta Pharma Limited, (Reuters: AJPH.NS, Bloomberg: AJP:IN, NSE: AJANTPHARM, BSE: 532331), today announced that it has received final approval of Almotriptan Mhalate Tablets (6.25 mg & 12.5 mg), a generic version of Axert@" for the treatment of acute migraine pain relief, from the U.S. Food and Drug Administration (FDA). Ajanta Pharma USA Inc., a wholly owned subsidiary of Ajanta Pharma Ltd, is scheduled to launch Almotriptan Tablets in US shortly. Almotriptan Tablets is part of an ever-growing portfolio that Ajanta Pharma has developed for the US market. To date, FDA has granted Ajanta Pharma eight ANDA final approvals. and two tentative approvals. An additional 16 ANDAs are under review with FDA. About Ajanta Pharma Ajanta Pharma Limited 1s a fully-integrated pharmaceutical company with global headquarters in Mumbai, India. Over 6,000 employees are engaged in developing, ‘manufacturing and marketing of quality finished dosages across 35 countries. For more details about Ajanta Pharma USA Inc., please visit. us at weww.ajantapharmausa.com. For Ajanta Pharma Ltd., you may visit us at www.ajantapharma.com, For specific queries, contact: Rajeev Agarwal Tel: +91 22 66061377 Email: rajcev.agarval@ajantapharma.com "axert is a registered trademark of Janssen Pharmaceuticals Safe Harbour Statement, Page 1 of 1 Corporate Identity Number — 124230MH1979PLC022059